High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma.

about

High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma.

Item

http://www.wikidata.org/entity/Q46803143

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

High-dose chemotherapy and aut ...... r refractory Hodgkin lymphoma.

@en

High-dose chemotherapy and aut ...... r refractory Hodgkin lymphoma.

@nl

type

Item

label

High-dose chemotherapy and aut ...... r refractory Hodgkin lymphoma.

@en

High-dose chemotherapy and aut ...... r refractory Hodgkin lymphoma.

@nl

prefLabel

High-dose chemotherapy and aut ...... r refractory Hodgkin lymphoma.

@en

High-dose chemotherapy and aut ...... r refractory Hodgkin lymphoma.

@nl

P1476

High-dose chemotherapy and aut ...... r refractory Hodgkin lymphoma.

@en

P2093

Chan-Sik Park

http://www.w3.org/2001/XMLSchema#string

Cheolwon Suh

http://www.w3.org/2001/XMLSchema#string

Dok Hyun Yoon

http://www.w3.org/2001/XMLSchema#string

Jooryung Huh

http://www.w3.org/2001/XMLSchema#string

Kwonoh Park

http://www.w3.org/2001/XMLSchema#string

Sang-Wook Lee

http://www.w3.org/2001/XMLSchema#string

Shin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of the stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group pilot study E1492

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The

Hodgkin lymphoma: an update on its biology with new insights into classification.

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

ESHAP is an active regimen for relapsing Hodgkin's disease.

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001-2006.

P2888

s12185-013-1267-2

P304

256-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-013-1267-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23355263

http://www.w3.org/2001/XMLSchema#string